ArticlePediatrics international : official journal of the Japan Pediatric Society
Sleep Disturbances in Children Aged 3-36 Months With Atopic Dermatitis and Their Association With Parental Sleep Quality.
Article in Pediatrics international : official journal of the Japan Pediatric Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSleep disturbances are among the most burdensome consequences of atopic dermatitis (AD), yet data on infant sleep and its impact on parental sleep quality remain limited. To evaluate sleep characteristics in infants with AD, assess parental sleep quality, and investigate the associations between disease severity, infant sleep disturbances, and parental sleep outcomes.
methodsIn this controlled cross-sectional study, 55 infants aged 3-36 months with AD and 60 age-matched healthy controls were enrolled. Disease severity was assessed using the SCORAD index. Infant sleep was evaluated with the Brief Infant Sleep Questionnaire-Revised (BISQ-R), and parental sleep quality with the Pittsburgh Sleep Quality Index (PSQI). Multivariable logistic regression was performed to identify factors independently associated with infant and parental sleep impairment.
resultsCompared with healthy controls, infants with AD had significantly shorter nighttime sleep duration, longer nighttime wakefulness, and a higher prevalence of poor sleeper status (56.4% vs. 30.0%, p = 0.004). Parents of infants with AD had significantly higher global PSQI scores and a greater prevalence of poor sleep quality (50.9% vs. 28.3%, p = 0.013). Poor sleeper status was strongly associated with poor parental sleep quality (p < 0.001). Increasing SCORAD scores independently predicted both infant sleep impairment (OR = 1.06, 95% CI 1.01-1.11) and poor parental sleep quality (OR = 1.07, 95% CI 1.01-1.12).
conclusionsAD is associated with significant impairment of both infant and parental sleep, with sleep disturbances becoming more pronounced as disease severity increases. The close relationship between infant and parental sleep highlights the importance of incorporating routine sleep assessment into the family-centered clinical management of infants with AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.